231 related articles for article (PubMed ID: 34520111)
1. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
Eddy KE; Vogel JP; Zahroh RI; Bohren MA
BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
[TBL] [Abstract][Full Text] [Related]
2. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
Ridge AL; Bero LA; Hill SR
BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.
Oguntunde O; Charyeva Z; Cannon M; Sambisa W; Orobaton N; Kabo IA; Shoretire K; Danladi SE; Lawal N; Sadauki H
BMC Pregnancy Childbirth; 2015 Jun; 15():130. PubMed ID: 26037906
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
Long Q; Oladapo OT; Leathersich S; Vogel JP; Carroli G; Lumbiganon P; Qureshi Z; Gülmezoglu AM;
BJOG; 2017 Nov; 124(12):1883-1890. PubMed ID: 27885772
[TBL] [Abstract][Full Text] [Related]
5. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
[TBL] [Abstract][Full Text] [Related]
6. Availability of treatment for eclampsia in public health institutions in Maharashtra, India.
Chaturvedi S; Randive B; Mistry N
J Health Popul Nutr; 2013 Mar; 31(1):86-95. PubMed ID: 23617209
[TBL] [Abstract][Full Text] [Related]
7. Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice.
Bigdeli M; Zafar S; Assad H; Ghaffar A
PLoS One; 2013; 8(3):e59158. PubMed ID: 23555626
[TBL] [Abstract][Full Text] [Related]
8. Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.
Tukur J; Ahonsi B; Ishaku SM; Araoyinbo I; Okereke E; Babatunde AO
Matern Child Health J; 2013 Sep; 17(7):1191-8. PubMed ID: 22956402
[TBL] [Abstract][Full Text] [Related]
9. [MgSO4-therapy in pre-eclampsia/eclampsia. Review of the literature].
Minkov R; Aleksandrov K
Akush Ginekol (Sofiia); 2003; 42 Suppl 2():24-7. PubMed ID: 14619751
[No Abstract] [Full Text] [Related]
10. Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis.
Zahroh RI; Hazfiarini A; Eddy KE; Vogel JP; Tunçalp Ӧ; Minckas N; Althabe F; Oladapo OT; Bohren MA
PLoS Med; 2022 Aug; 19(8):e1004074. PubMed ID: 35998205
[TBL] [Abstract][Full Text] [Related]
11. The WHO Safe Childbirth Checklist implementation: impact on the prescription of magnesium sulphate through a one-year longitudinal study.
da Silva Gama ZA; Medeiros WR; Saturno-Hernández PJ; de Meneses Sousa K; Mello MS; de Lima Vale É; de Souza Rosendo TMS; da Silva EMM; de Freitas MR
BMC Pregnancy Childbirth; 2020 Mar; 20(1):154. PubMed ID: 32164643
[TBL] [Abstract][Full Text] [Related]
12. [Magnesium sulfate in obstetrics: current data].
Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
Okusanya BO; Oladapo OT; Long Q; Lumbiganon P; Carroli G; Qureshi Z; Duley L; Souza JP; Gülmezoglu AM
BJOG; 2016 Feb; 123(3):356-66. PubMed ID: 26599617
[TBL] [Abstract][Full Text] [Related]
14. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.
Lu JF; Nightingale CH
Clin Pharmacokinet; 2000 Apr; 38(4):305-14. PubMed ID: 10803454
[TBL] [Abstract][Full Text] [Related]
15. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals.
Barua A; Mundle S; Bracken H; Easterling T; Winikoff B
Int J Gynaecol Obstet; 2011 Dec; 115(3):231-4. PubMed ID: 21930268
[TBL] [Abstract][Full Text] [Related]
16. Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres.
De Silva DA; Sawchuck D; von Dadelszen P; Basso M; Synnes AR; Liston RM; Magee LA
J Obstet Gynaecol Can; 2015 Nov; 37(11):975-87. PubMed ID: 26629718
[TBL] [Abstract][Full Text] [Related]
17. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
[TBL] [Abstract][Full Text] [Related]
18. Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies.
Pratt JJ; Niedle PS; Vogel JP; Oladapo OT; Bohren M; Tunçalp Ö; Gülmezoglu AM
Acta Obstet Gynecol Scand; 2016 Feb; 95(2):144-56. PubMed ID: 26485229
[TBL] [Abstract][Full Text] [Related]
19. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.
Aaserud M; Lewin S; Innvaer S; Paulsen EJ; Dahlgren AT; Trommald M; Duley L; Zwarenstein M; Oxman AD
BMC Health Serv Res; 2005 Nov; 5():68. PubMed ID: 16262902
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
